Fresenius Medical Care Asia Pacific Receives Prestigious ACHS Global Quality...
HONG KONG Fresenius Medical Care, the world’s leading provider of products and services for individuals with renal diseases, was presented with the prestigious Australian Council for Healthcare...
View ArticleiXensor Confirms PixoTest® COVID-19 Antigen Test Detects Omicron and Other...
TAIPEI, Taiwan iXensor Co., Ltd. (6734.TWO) This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211222005223/en/ iXensor’s PixoTest COVID-19...
View ArticleLigand’s Partner CStone Pharmaceuticals Receives Approval in China for...
EMERYVILLE, Calif. Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) today announced that its partner CStone Pharmaceuticals (HKEX: 2616) has received approval from China’s National Medical...
View ArticleBabson Graduate Pooja Ika Launches eternalHealth, the First New Medicare...
BOSTON eternalHealth, the first new health plan to be approved in Massachusetts since 2013, has officially announced its launch of the company, delivering high-quality and affordable Medicare...
View ArticleAlentis Therapeutics启动旨在治疗肝肾纤维化的首次人体临床试验
瑞士巴塞尔 (美国商业资讯)–Alentis Therapeutics, AG今天宣布,该公司已在ALE.F02首次人体一期临床试验中对第一批健康受试者进行给药。ALE.F02是一种对Claudin-1呈高度选择性的单克隆抗体,目前正用于开发针对无适当医药的晚期肝肾纤维化的疗法。Alentis是一家临床阶段生物制药公司,专注于发现和开发面向无适当医药的纤维化疾病的突破性疗法。...
View ArticleNew Frontier Health Corporation Announces Shareholders’ Approval of Merger...
BEIJING New Frontier Health Corporation (“NFH” or the “Company”) (NYSE: NFH), operator of the premium healthcare services provider United Family Healthcare, today announced that, at an extraordinary...
View ArticleNew Frontier Health Corporation Receives Notification from NYSE Regarding...
BEIJING New Frontier Health Corporation (NYSE: NFH) (“NFH” or the “Company”), the operator of the premium healthcare services provider United Family Healthcare, today reported that, on January 4,...
View ArticlePerceval: CORCYM Announces the First Patient Implanted in China
LONDON CORCYM, the medical device company dedicated to providing patients and cardiac surgeons with the best solutions to fight structural heart disease, announces today the first Perceval implant...
View ArticleCORCYM宣布在中国对首例患者实施Perceval植入
伦敦 (美国商业资讯)–CORCYM是一家医疗设备公司,致力于为患者和心脏外科医生提供用于治疗结构性心脏病的一流解决方案。在近期获得中国国家药品监督管理局(NMPA)的批准后,CORCYM今天宣布在中国实施首次Perceval植入。 Perceval是一种采用免缝合、可压缩设计的生物主动脉瓣,可简化手术植入,减少手术的影响,并加快患者康复1,2 。...
View ArticleリバプールCCGとコミュニティー・ファーマシー・リバプールが100軒以上の地域薬局でFebriDx®サービスを開始
英リバプール (ビジネスワイヤ) — 本日、リバプール・クリニカル・コミッショニング・グループ(CCG)とコミュニティー・ファーマシー・リバプールは、100軒以上の薬局で10分間のポイントオブケア検査を行い、細菌性とウイルス性の呼吸器感染症を判別する新しい臨床サービスを開始しました。...
View ArticleLiverpool CCG和Community Pharmacy Liverpool在100多家社区药房推出FebriDx®服务
英格兰利物浦 (美国商业资讯)–今天,Liverpool Clinical Commissioning Group (CCG)和Community Pharmacy Liverpool启动了一项新的临床服务,支持100多家药房提供10分钟即时检测服务,以区分细菌性和病毒性呼吸道感染。 本新闻稿包含多媒体。此处查看新闻稿全文:...
View ArticleMavenir通过电信管理论坛Catalyst Ecosoft eHealth计划带来动态网络切片创新
德州理查森 (美国商业资讯)–Mavenir是一家网络软件提供商,致力于利用可以在任何云上运行并改变世界连接方式的云原生软件来构建面向未来的网络。该公司今天宣布其已顺利完成动态网络切片和实现,为行业重大挑战带来创新型解决方案。这项工作是最近结束的2021年电信管理论坛(TM Forum)“Ecosoft eHealth”催化剂计划的一部分。...
View ArticleマベニアがTMフォーラムの「エコソフトeヘルス」カタリスト・プロジェクトを通じて動的なネットワークスライシングの革新を実現
米テキサス州リチャードソン (ビジネスワイヤ) —...
View ArticleMerck Provides U.S. and Japan Regulatory Update for Gefapixant
KENILWORTH, N.J. Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL)...
View ArticleENDRA Life Sciences Expands into China with Shanghai General Hospital...
ANN ARBOR, Mich. ENDRA Life Sciences Inc. (ENDRA) (NASDAQ: NDRA), a pioneer of enhanced ultrasound technologies, today announced it has received Institutional Review Board approval from China’s...
View ArticleMore than two in five Australians seek workplace flexibility
MELBOURNE, Australia LifeWorks, a leading provider of digital and in-person total wellbeing solutions, today released its monthly Mental Health Index™, revealing a negative mental health score among...
View Article艺康将UVD Robots纳入集团的全球感染预防产品,以帮助降低医院获得性感染
丹麦欧登塞 (美国商业资讯)–随着新型冠状病毒变种的传播,市场对基于UV-C紫外线光的感染预防解决方案需求大增,预计到2030年将达189.4亿美元,从2021年至2030年的年均增长率高达59.7%。推动需求的另一个因素是全球医院获得性感染(HAI)增加并造成更多的死亡,原因是抗生素耐药性的增加,即使是单纯性感染。 本新闻稿包含多媒体。此处查看新闻稿全文:...
View ArticleFlatiron Health Announces RWD Partnership With Japan’s NCCHE
NEW YORK Flatiron HealthⓇ today announced a partnership with Japan’s National Cancer Center Hospital East (NCCHE) to build a real-world database of patients with gastro-intestinal cancers. “Insights...
View ArticleNew Frontier Health Corporation Announces Completion of Going Private...
BEIJING New Frontier Health Corporation (“NFH” or the “Company”) (NYSE: NFH), operator of the premium healthcare services provider United Family Healthcare, today announced the completion of its...
View Article